Lansoprazole and Sodium Bicarbonate for Suspcnsion(Nanjing Haina Medicine Tech)

兰索拉唑碳酸氢钠干混悬剂(南京海纳医药)

Report date: 2026/05/27 15:07:28

Base Information

Drug NameLansoprazole and Sodium Bicarbonate for Suspcnsion(Nanjing Haina Medicine Tech)
Drug Alias Name兰索拉唑碳酸氢钠干混悬剂(2.2类改良型)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsStomach UlcerDuodenal UlcerEsophagitis, Peptic +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Active IndicationsStomach UlcerDuodenal UlcerEsophagitis, Peptic +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A